Apr 25, 2022
The use of mobile devices, social media, wearables, and other biosensors continues to expand year on year. The curation and analyses of health-related data is accelerating, and these data provide the potential to answer questions previously thought infeasible. When a researcher is seeking answers to a health question, when is it appropriate to use real-world data (RWD) and when it is appropriate to conduct clinical research? In this episode, Dr. Susan Dallabrida, CEO, SPRIM Consulting, and Dr. Carla Rodriguez-Watson, Director of Research, Reagan-Udall Foundation for the FDA, share their extensive experiences with RWD and real-world evidence (RWE).